PX1 Research provides high-purity GLP-2 (Glucagon-Like Peptide-2) strictly synthesized for laboratory research, in vitro assays, and preclinical animal models. Each lot undergoes comprehensive analytical characterization to ensure maximum batch-to-batch consistency and structural purity for scientific investigators.
PX1 Research provides high-purity GLP-2 (Glucagon-Like Peptide-2) strictly synthesized for laboratory research, in vitro assays, and preclinical animal models. Each lot undergoes comprehensive analytical characterization to ensure maximum batch-to-batch consistency and structural purity for scientific investigators.
High-purity GLP-2 for sale is available to academic institutions, biotechnology organizations, and independent research laboratories through specialized peptide suppliers like PX1 Research. Intended exclusively for in vitro cell culture studies and preclinical animal models, research-grade GLP-2 is fully characterized via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) to guarantee high chemical purity and reproducible experimental outcomes.
When purchasing GLP-2 for experimental research, verifying the structural identity, purity, and safety profile of the compound is essential. Minor sequence variations, residual trifluoroacetic acid (TFA), or heavy metal contaminants can skew receptor binding assays, alter signaling cascades, or cause uncharacteristic cellular toxicity. Sourcing through validated US manufacturers who provide full chemical transparency via a batch-specific Certificate of Analysis (COA) mitigates these confounding variables.
Glucagon-Like Peptide-2 (GLP-2) is a 33-amino acid peptide derived from the specific post-translational cleavage of proglucagon in intestinal L-cells and central nervous system neurons. Sequence analysis indicates that GLP-2 belongs to the secretin/glucagon superfamily, sharing structural homology with related metabolic signaling peptides. Investigators studying gastrointestinal architecture frequently evaluate research peptides across this family to delineate distinct mucosal signaling cascades.
In physiological systems, native GLP-2 acts as a target-specific trophic hormone. It selectively binds to the GLP-2 receptor (GLP-2R), a class B G-protein-coupled receptor (GPCR) primary expressed on subepithelial myofibroblasts, enteric neurons, and enteroendocrine cells. Receptor activation initiates intracellular cyclic adenosine monophosphate (cAMP) accumulation and downstream protein kinase A (PKA) signaling, promoting cellular survival and tissue proliferation. To inspect primary source materials and exact molecular configurations, researchers can review our dedicated GLP-2 research peptide specification page.
Preclinical investigation into GLP-2 has primary focused on intestinal adaptation, enterocyte proliferation, and epithelial integrity. In animal models of intestinal resection or mucosal injury, administration of GLP-2 analogues demonstrates a significant reduction in enterocyte apoptosis combined with stimulated crypt cell proliferation. These tissue alterations result in expanded villus height, increased mucosal weight, and improved absorptive capacity across small bowel segments.
In vitro data indicate that GLP-2 exposure enhances tight junction protein expression—including occludin, claudin-1, and zonula occludens-1 (ZO-1)—in intestinal epithelial cell culture models. By stabilizing these intercellular junctions, GLP-2 limits paracellular permeability and reduces baseline endotoxin translocation across degraded epithelial sheets. Detailed mechanistical literature on gut permeability models is indexed in our peptide research library.
Although derived from the identical precursor gene, GLP-2 exhibits distinct physiological targets and mechanisms compared to other proglucagon-derived signaling molecules. While GLP-1 primarily regulates glucose homeostasis, gastric emptying, and insulin secretion, GLP-2 acts selectively as an enterotrophic growth factor dedicated to intestinal tissue maintenance and mucosal repair.
In laboratory comparison studies, researchers frequently evaluate GLP-2 alongside related incretins and trophic peptides to analyze receptor specificity and synergistic gut signaling. For example, investigating GLP-1 mechanisms alongside GLP-2 allows scientists to map differential receptor cross-talk in dual-transgenic animal lines. Furthermore, synthetic long-acting agonists like Semaglutide and multi-receptor peptides such as Tirzepatide target systemic metabolic signaling, whereas GLP-2 analogues remain predominantly localized in their structural actions on the intestinal mucosa.
Ensuring experimental reproducibility requires rigorous quality control standards for every lot of GLP-2. Unverified or low-grade peptide reagents frequently contain truncated sequences, deletion peptides, or synthesis byproducts that interfere with biological assay outcomes. A dependable research supplier must provide comprehensive analytical validation for every batch dispatched to a laboratory setting.
PX1 Research enforces strict quality assurance criteria across all peptide offerings. Every lot of GLP-2 undergoes dual-stage verification: RP-HPLC to confirm molecular purity levels typically exceeding 98%, and Mass Spectrometry (MS) to verify precise molecular weight and amino acid sequencing. Additionally, bacterial endotoxin testing (LAL assay) is conducted to ensure levels remain well within acceptable limits for sensitive in vitro cell culture and live-animal research protocols.
Lyophilized GLP-2 is supplied as a stable, freeze-dried powder. Upon arrival, unopened vials should be stored at -20°C or -80°C in a desiccated environment to maintain long-term peptide stability and prevent degradation via moisture absorption.
For laboratory reconstitution, researchers should use sterile bacteriostatic water, sterile normal saline, or appropriate laboratory buffers depending on the target assay. Reconstitution should be performed by gently swirling or reconstituting down the inner vial wall; vigorous vortexing should be avoided to prevent protein aggregation or mechanical shearing. Once reconstituted, liquid aliquots should be stored at -20°C or colder to prevent freeze-thaw degradation cycles. Further experimental guidelines on handling enteric target compounds are detailed in our guide to gut barrier research peptides.
In vitro models utilizing Caco-2, IEC-6, or primary intestinal organoid cultures rely on highly purified GLP-2 to evaluate cellular growth dynamics, brush-border enzyme activity, and nutrient transport kinetics. Precise concentration gradients allow investigators to map GLP-2R affinity constants, receptor internalization trajectories, and second-messenger signal cascades without interference from vehicle impurities.
In preclinical rodent models—such as dextran sulfate sodium (DSS)-induced colitis or ischemia-reperfusion intestinal injury models—GLP-2 is evaluated for its protective effects against mucosal destruction. Researchers track biomarkers including villus height, crypt depth, mucosal DNA/protein content, and tissue-specific inflammatory cytokines (e.g., TNF-alpha, IL-6) to assess the biological activity of the tested peptide lot.
High-throughput screening setups, longitudinal animal studies, and institutional research projects frequently require substantial quantities of GLP-2 from a single, homogeneous synthesis lot. Using consistent lots across multi-month experimental timelines eliminates lot-to-lot variability as a confounding experimental factor.
PX1 Research supports university laboratories, CROs, and biotech institutions with scalable bulk supply options. Qualified researchers seeking custom synthesis runs, custom packaging configurations, or volume-tier pricing can establish a dedicated account through our wholesale peptide program.
PX1 Research is dedicated to supporting the scientific community by manufacturing and distributing research-use-only peptides under stringent quality standards. Operating out of state-of-the-art facilities located in California and Arizona, our operations strictly adhere to ISO 17025 laboratory standards and GMP-compliant manufacturing frameworks.
Every sequence offered by PX1 Research includes batch-specific analytical documentation, full lot traceability, and rapid dispatch. Orders placed Monday through Friday ship same-day from our CA and AZ facilities, ensuring that temperature-sensitive research compounds arrive at your laboratory quickly and in optimal condition.
Is GLP-2 offered by PX1 Research suitable for human administration?
No. GLP-2 and all products distributed by PX1 Research are strictly intended for laboratory research, in vitro assays, and preclinical animal models. They are not for human or veterinary use, medical diagnosis, treatment, or therapeutic administration.
What purity level can be expected from PX1 Research GLP-2?
Every lot of GLP-2 supplied by PX1 Research is verified via RP-HPLC to possess a chemical purity level of 98% or greater. Batch-specific analytical results are available on the lot Certificate of Analysis (COA).
How is the molecular identity of GLP-2 confirmed?
Molecular identity and exact sequence composition are verified using Mass Spectrometry (MS) to confirm that the observed mass matches the calculated theoretical molecular weight of the 33-amino acid GLP-2 sequence.
What solvent is recommended for reconstituting lyophilized GLP-2?
GLP-2 is typically reconstituted using sterile bacteriostatic water, sterile normal saline, or standard laboratory buffer solutions such as PBS, depending on the requirements of the specific cell culture or animal model assay.
How should reconstituted GLP-2 solutions be stored in the lab?
Once reconstituted into solution, GLP-2 should be divided into single-use experimental aliquots and stored at -20°C or -80°C. Repeated freeze-thaw cycles must be avoided to prevent peptide degradation.
Are endotoxin levels tested for GLP-2 batches?
Yes. Every batch undergoes chromogenic LAL endotoxin testing to ensure low endotoxin levels suitable for delicate primary cell cultures and sensitive animal studies.
What is the primary difference between GLP-1 and GLP-2 in preclinical research?
Although both originate from proglucagon, GLP-1 primarily acts on pancreatic and metabolic signaling pathways involved in glucose control, whereas GLP-2 acts selectively as an enterotrophic peptide targeting gut mucosal growth and barrier integrity.
Can PX1 Research provide bulk quantities of GLP-2 for large preclinical trials?
Yes. PX1 Research supplies custom lot sizes and institutional bulk orders for high-throughput screening or multi-phase animal studies through our wholesale department.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.